HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jean-Francois Baurain Selected Research
Jean-Francois Baurain Research Topics
Disease
6
Neoplasms (Cancer)
03/2022 - 03/2009
3
Glioblastoma (Glioblastoma Multiforme)
01/2022 - 03/2009
3
Breast Neoplasms (Breast Cancer)
10/2019 - 11/2011
2
Ovarian Neoplasms (Ovarian Cancer)
10/2019 - 01/2013
1
Melanoma (Melanoma, Malignant)
03/2022
1
Central Nervous System Neoplasms
01/2022
1
Astrocytoma (Pilocytic Astrocytoma)
01/2022
1
Uveal melanoma
01/2021
1
Exanthema (Rash)
01/2021
1
Fever (Fevers)
01/2021
1
Necrosis
01/2021
1
Pruritus (Itching)
01/2021
1
Disease Progression
01/2021
1
Sarcoma (Soft Tissue Sarcoma)
10/2019
1
Pancreatic Neoplasms (Pancreatic Cancer)
10/2019
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2019
1
Transitional Cell Carcinoma
10/2019
1
Oligomenorrhea
01/2013
1
Amenorrhea
01/2013
1
Prostatic Neoplasms (Prostate Cancer)
01/2013
1
Peripheral Nervous System Diseases (PNS Diseases)
01/2013
1
Headache (Headaches)
11/2011
1
Asthenia
11/2011
1
Pleural Effusion (Pleural Effusions)
11/2011
1
Brain Neoplasms (Brain Tumor)
03/2009
Drug/Important Bio-Agent (IBA)
2
Temozolomide (Temodar)
FDA Link
Generic
01/2022 - 03/2009
2
ErbB Receptors (EGF Receptor)
IBA
11/2011 - 03/2009
1
Antibodies
IBA
03/2022
1
Programmed Cell Death 1 Receptor
IBA
03/2022
1
Immune Checkpoint Inhibitors
IBA
03/2022
1
Neoplasm Antigens (Tumor Antigens)
IBA
03/2022
1
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
01/2022
1
Peptides (Polypeptides)
IBA
01/2021
1
tebentafusp
IBA
01/2021
1
pembrolizumab
IBA
01/2021
1
Ipilimumab
IBA
01/2021
1
Dacarbazine (DIC)
FDA Link
Generic
01/2021
1
Glycoproteins (Glycoprotein)
IBA
01/2021
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
01/2021
1
LTX-315
IBA
01/2021
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2021
1
HLA-A Antigens (HLA-A)
IBA
01/2021
1
Cytokines
IBA
01/2021
1
brivanib
IBA
10/2019
1
Bevacizumab (Avastin)
FDA Link
03/2015
1
Epothilones (Epothilone)
IBA
01/2013
1
Tamoxifen
FDA Link
Generic
01/2013
1
sagopilone
IBA
01/2013
1
Biological Products
IBA
01/2013
1
Estrogens (Estrogen)
FDA Link
01/2013
1
Acetylcarnitine (Alcar)
IBA
01/2013
1
Tyrosine Kinase Inhibitors
IBA
11/2011
1
Dasatinib (BMS 354825)
FDA Link
11/2011
1
Pharmaceutical Preparations
IBA
11/2011
1
Hormones (Hormone)
IBA
11/2011
1
epidermal growth factor receptor VIII
IBA
03/2009
1
Carmustine (FIVB)
FDA Link
03/2009
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
03/2009
Therapy/Procedure
2
Therapeutics
01/2021 - 01/2013
2
Drug Therapy (Chemotherapy)
01/2013 - 11/2011
1
Immunotherapy
03/2022
1
Radiotherapy
01/2022
1
Aftercare (After-Treatment)
01/2021
1
Injections
01/2021
1
Castration
01/2013